OI
Therapeutic Areas
Medmain Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PidPort AI Analysis | Pathological screening of tissue and cells | Commercial |
| Ki-67 Labeling Index AI | Assessment in immunohistochemical specimens | Research/Development |
| Drug | Indication | Phase |
|---|---|---|
| PidPort AI Analysis | Pathological screening of tissue and cells | Commercial |
| Ki-67 Labeling Index AI | Assessment in immunohistochemical specimens | Research/Development |